相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts
Xing Yi Woo et al.
NATURE GENETICS (2021)
Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor NCI-MATCH Subprotocol EAY131-Y Nonrandomized Trial
Kevin Kalinsky et al.
JAMA ONCOLOGY (2021)
FiNGS: high quality somatic mutations using filters for next generation sequencing
Christopher Paul Wardell et al.
BMC BIOINFORMATICS (2021)
An update on the central nervous system manifestations of Li-Fraumeni syndrome
Brent A. Orr et al.
ACTA NEUROPATHOLOGICA (2020)
A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity
Fadi Jacob et al.
CELL (2020)
The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design
Keith T. Flaherty et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
An Update on Neurofibromatosis Type 1-Associated Gliomas
Mina Lobbous et al.
CANCERS (2020)
Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic features
Emily A. Sloan et al.
ACTA NEUROPATHOLOGICA (2020)
Targeting IFN/STAT1 Pathway as a Promising Strategy to Overcome Radioresistance
Shuya Liu et al.
ONCOTARGETS AND THERAPY (2020)
A Patient-Derived Cell Atlas Informs Precision Targeting of Glioblastoma
Patrik Johansson et al.
CELL REPORTS (2020)
Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)
Keith T. Flaherty et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma
Ae Kyung Park et al.
NEURO-ONCOLOGY (2019)
Modeling Patient-Derived Glioblastoma with Cerebral Organoids
Amanda Linkous et al.
CELL REPORTS (2019)
Acquired temozolomide resistance in MGMT-deficient glioblastoma cells is associated with regulation of DNA repair by DHC2
Guo-Zhong Yi et al.
BRAIN (2019)
Prospective Validation of an Ex Vivo, Patient-Derived 3D Spheroid Model for Response Predictions in Newly Diagnosed Ovarian Cancer
Stephen Shuford et al.
SCIENTIFIC REPORTS (2019)
Integrated genomic profiling expands clinical options for patients with cancer
Nike Beaubier et al.
NATURE BIOTECHNOLOGY (2019)
A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids
Nhan Phan et al.
COMMUNICATIONS BIOLOGY (2019)
Comparative Tumor RNA Sequencing Analysis for Difficult-to-Treat Pediatric and Young Adult Patients With Cancer
Olena M. Vaske et al.
JAMA NETWORK OPEN (2019)
A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913
Prakash Chinnaiyan et al.
NEURO-ONCOLOGY (2018)
Replication Stress Drives Constitutive Activation of the DNA Damage Response and Radioresistance in Glioblastoma Stem-like Cells
Ross D. Carruthers et al.
CANCER RESEARCH (2018)
Strelka2: fast and accurate calling of germline and somatic variants
Sangtae Kim et al.
NATURE METHODS (2018)
Toil enables reproducible, open source, big biomedical data analyses
John Vivian et al.
NATURE BIOTECHNOLOGY (2017)
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2017)
DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells
Hiro Sato et al.
NATURE COMMUNICATIONS (2017)
The good and the bad faces of STAT1 in solid tumours
Katrin Meissl et al.
CYTOKINE (2017)
TumorMap: Exploring the Molecular Similarities of Cancer Samples in an Interactive Portal
Yulia Newton et al.
CANCER RESEARCH (2017)
Universal Patterns of Selection in Cancer and Somatic Tissues
Inigo Martincorena et al.
CELL (2017)
High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients
Sung-Yup Cho et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
Expression and Prognostic Significance of p53 in Glioma Patients: A Meta-analysis
Yueling Jin et al.
NEUROCHEMICAL RESEARCH (2016)
MiRNA203 suppresses the expression of protumorigenic STAT1 in glioblastoma to inhibit tumorigenesis
Chuan He Yang et al.
ONCOTARGET (2016)
The impact of amplification on differential expression analyses by RNA-seq
Swati Parekh et al.
SCIENTIFIC REPORTS (2016)
The Ensembl Variant Effect Predictor
William McLaren et al.
GENOME BIOLOGY (2016)
Gain of Function of Mutant TP53 in Glioblastoma: Prognosis and Response to Temozolomide
Xiang Wang et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Heterogeneity of Li-Fraumeni Syndrome links to unequal gain-of-function effects of p53 mutations
Jie Xu et al.
SCIENTIFIC REPORTS (2014)
Decoupling of DNA damage response signaling from DNA damages underlies temozolomide resistance in glioblastoma cells
Bo Cui et al.
JOURNAL OF BIOMEDICAL RESEARCH (2010)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
